Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Processa Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of Next Generation Cancer therapy (NGC) small molecules. Its oncology pipeline consists of NGC-Cap and NGC-Iri (also identified as PCS6422 and PCS11T, respectively) and two non-oncology drugs (PCS12852 and PCS499). NGC-Cap is a combination of PCS6422 and capecitabine, capecitabine being the oral prodrug of the cancer drug 5-fluorouracil. PCS3117 is an oral analog of gemcitabine that is converted to its active metabolite by a different enzyme system than gemcitabine. PCS11T is a prodrug of the active metabolite of irinotecan. PCS12852 is a specific and potent 5HT4 agonist that is in Phase IIB and is a potential treatment for diabetic gastroparesis patients. PCS499 is a drug that can be used to treat unmet medical needs and conditions caused by multiple pathophysiological changes. Its pipelines also include VT-7208, a Bruton's tyrosine kinase inhibitor therapy for immune-mediated diseases.
Find out what a historical investment in Processa Pharmaceuticals Inc would be worth today using our PCSA stock calculator.
Buying PCSA shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Processa Pharmaceuticals Inc in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in PCSA
What is the ticker symbol of Processa Pharmaceuticals Inc?
The ticker symbol for Processa Pharmaceuticals Inc is PCSA.
How much is one share of PCSA?
One share of PCSA is valued at $1.69 as of 20 November 2026.
What is the market capitalisation of Processa Pharmaceuticals Inc PCSA?
As of 20 November 2026 Processa Pharmaceuticals Inc has a market cap of $4.76M.
What is the 52-week high for Processa Pharmaceuticals Inc stock?
The Processa Pharmaceuticals Inc 52-week high stock price is $8.88.
What is the 52-week low for Processa Pharmaceuticals Inc stock?
The Processa Pharmaceuticals Inc 52-week low stock price is $1.04.
Can I buy PCSA shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy PCSA shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in PCSA on Stake
Buy PCSA from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of PCSA from only US$10 with fractional shares